ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newall, F.
Right arrow Articles by Monagle, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newall, F.
Right arrow Articles by Monagle, P.
Related Collections
Right arrow Extracorporeal circulation
Right arrowRelated Article

Ann Thorac Surg 2006;81:1944
© 2006 The Society of Thoracic Surgeons

Correspondence

Temporal Aspects of Anti-Heparin-PF4 Antibodies in Heparin-Induced Thrombocytopenia

Fiona Newall, MN a , Vera Ignjatovic, PhD b , Paul Monagle, MD c

a Department of Clinical Haematology, Royal Children's Hospital, Flemington Rd, Parkville, Victoria, 3052 Australia
b Murdoch Children's Research Institute, Flemington Rd, Parkville, Victoria, 3052 Australia
c Department of Pathology, The University of Melbourne, Royal Pde, Carlton, 3053 Australia

(Email: fiona.newall@rch.org.au; verai@unimelb.edu.au; paul.monagle@rch.org.au).

The first 20% of the full text of this article appears below.

To the Editor:

We would like to comment on the article by Böning and colleagues discussing the incidence of heparin-induced thrombocytopenia in pediatric patients undergoing cardiothoracic surgery [1]. The authors present a study whereby children who have undergone previous cardiopulmonary bypass (CPB) are screened for the presence of anti-heparin-PF4 antibodies prior to undergoing repeat CPB. Pediatric patients who have undergone CPB, necessitating supra-therapeutic heparin doses, represent a likely cohort in which . . . [Full Text of this Article]


Related Article

Reply
Andreas Böning and Jochen T. Cremer
Ann. Thorac. Surg. 2006 81: 1944-1945. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
A. Boning and J. T. Cremer
Reply.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1944 - 1945.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.